Nexium class includes members who haven't been injured, AstraZeneca tells court
By Can Celik ( July 31, 2014, 17:28 GMT | Insight) -- The inclusion of uninjured class members requires that the class certification be overturned in litigation alleging an illegal agreement to delay generic Nexium, counsel for AstraZeneca told a federal appeals court on Thursday.The inclusion of uninjured class members requires that the class certification be overturned in litigation alleging an illegal agreement to delay generic Nexium, counsel for AstraZeneca told a federal appeals court on Thursday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.